{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:14:24Z","timestamp":1770509664462,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T00:00:00Z","timestamp":1469491200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005632","name":"Forest Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005632","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s40272-016-0184-2","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T04:57:29Z","timestamp":1469509049000},"page":"367-378","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Long-term Safety of Asenapine in Pediatric Patients Diagnosed With Bipolar I Disorder: A 50-Week Open-Label, Flexible-Dose Trial"],"prefix":"10.1007","volume":"18","author":[{"given":"Robert L.","family":"Findling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald L.","family":"Landbloom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Mackle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Snow-Adami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiki","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh","family":"Durgam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,26]]},"reference":[{"key":"184_CR1","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/archgenpsychiatry.2012.38","volume":"69","author":"KR Merikangas","year":"2012","unstructured":"Merikangas KR, Cui L, Kattan G, Carlson GA, Youngstrom EA, Angst J. Mania with and without depression in a community samples of US adolescents. Arch Gen Psychiatry. 2012;69:943\u201351.","journal-title":"Arch Gen Psychiatry"},{"key":"184_CR2","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.4088\/JCP.10m06290","volume":"72","author":"AR Meter Van","year":"2011","unstructured":"Van Meter AR, Moreira AL, Youngstrom EA. Meta-analysis of epidemiologic studies of pediatric bipolar disorder. J Clin Psychiatry. 2011;72:1250\u20136.","journal-title":"J Clin Psychiatry"},{"key":"184_CR3","doi-asserted-by":"crossref","first-page":"e446","DOI":"10.1542\/peds.2008-0841","volume":"123","author":"AJ Freeman","year":"2009","unstructured":"Freeman AJ, Youngstrom EA, Michalak E, Siegel R, Meyers OI, Findling RL. Quality of life in pediatric bipolar disorder. Pediatrics. 2009;123:e446\u201352.","journal-title":"Pediatrics"},{"key":"184_CR4","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.biopsych.2004.01.022","volume":"55","author":"RH Perlis","year":"2004","unstructured":"Perlis RH, Miyahara S, Marangell LB, Wisniewski SR, Ostacher M, DelBello MP, et al. Long-term implications of early onset bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry. 2004;55:875\u201381.","journal-title":"Biol Psychiatry"},{"key":"184_CR5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/archpsyc.63.2.175","volume":"63","author":"B Birmaher","year":"2006","unstructured":"Birmaher B, Axelson D, Strober M, Gill MK, Valeri S, Chiappetta L, et al. Clinical course of children and adolescents with bipolar spectrum disorders. Arch Gen Psychiatry. 2006;63:175\u201383.","journal-title":"Arch Gen Psychiatry"},{"key":"184_CR6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1399-5618.2009.00686.x","volume":"11","author":"RH Perlis","year":"2009","unstructured":"Perlis RH, Dennehy EB, Miklowitz DJ, Delbello MP, Ostacher M, Calabrese JR, et al. Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study. Bipolar Disord. 2009;11:391\u2013400.","journal-title":"Bipolar Disord"},{"key":"184_CR7","doi-asserted-by":"crossref","first-page":"864","DOI":"10.4088\/JCP.08m04994yel","volume":"71","author":"RM Post","year":"2010","unstructured":"Post RM, Leverich GS, Kupka RW, Keck PE Jr, McElroy SL, Altshuler LL, et al. Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood. J Clin Psychiatry. 2010;71:864\u201372.","journal-title":"J Clin Psychiatry"},{"key":"184_CR8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1542\/peds.2012-0139","volume":"130","author":"FT Bourgeois","year":"2012","unstructured":"Bourgeois FT, Murthy S, Pinto C, Olson KL, Ioannidis JP, Mandl KD. Pediatric versus adult drug trials for conditions with high pediatric disease burden. Pediatrics. 2012;130:285\u201392.","journal-title":"Pediatrics"},{"key":"184_CR9","unstructured":"SAPHRIS [package insert] St. Louis: Actavis Inc.; 2015."},{"key":"184_CR10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s40272-013-0024-6","volume":"15","author":"S Caccia","year":"2013","unstructured":"Caccia S. Safety and pharmacokinetics of atypical antipsychotics in children and adolescents. Pediatr Drugs. 2013;15:217\u201333.","journal-title":"Pediatr Drugs."},{"key":"184_CR11","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jaac.2015.09.007","volume":"54","author":"RL Findling","year":"2015","unstructured":"Findling RL, Landbloom RL, Szegedi A, Koppenhaver J, Braat S, Zhu Q, et al. Asenapine for the acute treatment of pediatric manic or mixed episode of bipolar I disorder. J Am Acad Child Adolesc Psychiatry. 2015;54:1032\u201341.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"184_CR12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.schres.2005.02.013","volume":"76","author":"G Chouinard","year":"2005","unstructured":"Chouinard G, Margolese HC. Manual for the Extrapyramidal Symptom Rating Scale (ESRS). Schizophr Res. 2005;76:247\u201365.","journal-title":"Schizophr Res"},{"key":"184_CR13","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1176\/appi.ajp.2011.10111704","volume":"168","author":"K Posner","year":"2011","unstructured":"Posner K, Brown GK, Stanley B, Brent DA, Yershova KV, Oquendo MA, et al. The Columbia-Suicide Severity Rating scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011;168:1266\u201377.","journal-title":"Am J Psychiatry"},{"key":"184_CR14","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","volume":"366","author":"KG Alberti","year":"2005","unstructured":"Alberti KG, Zimmet P, Shaw J. The metabolic syndrome\u2014a new worldwide definition. Lancet. 2005;366:1059\u201362.","journal-title":"Lancet"},{"key":"184_CR15","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(07)60958-1","volume":"369","author":"KG Alberti","year":"2007","unstructured":"Alberti KG, Zimmet P, Shaw J. The metabolic syndrome in children and adolescents. Lancet. 2007;369:2059\u201361.","journal-title":"Lancet"},{"key":"184_CR16","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","volume":"133","author":"R Young","year":"1978","unstructured":"Young R, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133:429\u201335.","journal-title":"Br J Psychiatry"},{"key":"184_CR17","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00004583-199203000-00011","volume":"31","author":"MA Fristad","year":"1992","unstructured":"Fristad MA, Weller EB, Weller RA. The Mania Rating Scale: can it be used in children? A preliminary report. J Am Acad Child Adolesc Psychiatry. 1992;31:252\u20137.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"184_CR18","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1207\/S15374424JCCP3104_15","volume":"31","author":"EA Youngstrom","year":"2002","unstructured":"Youngstrom EA, Danielson CK, Findling RL, Gracious BL, Calabrese JR. Factor structure for the Young Mania Rating Scale for use with youths ages 5 to 17\u00a0years. J Clin Child Adolesc Psychol. 2002;31:567\u201372.","journal-title":"J Clin Child Adolesc Psychol."},{"key":"184_CR19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-1781(97)00123-6","volume":"73","author":"MK Spearing","year":"1997","unstructured":"Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W. Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res. 1997;73:159\u201371.","journal-title":"Psychiatry Res"},{"key":"184_CR20","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/biomet\/26.4.404","volume":"26","author":"CJ Clopper","year":"1934","unstructured":"Clopper CJ, Pearson ES. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika. 1934;26:404\u201312.","journal-title":"Biometrika"},{"key":"184_CR21","unstructured":"Centers for Disease Control and Prevention: a SAS Program for the 2000 CDC Growth Charts (ages 0 to\u00a0<20\u00a0y), 2014. http:\/\/www.cdc.gov\/nccdphp\/dnpao\/growthcharts\/resources\/sas.htm . Accessed 23 July 2015."},{"key":"184_CR22","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.eurpsy.2010.09.011","volume":"26","author":"M Hert De","year":"2011","unstructured":"De Hert M, Dobbelaere M, Sheridan EM, Cohen D, Correll CU. Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: a systematic review of randomized, placebo controlled trials and guidelines for clinical practice. Eur Psychiatry. 2011;26:144\u201358.","journal-title":"Eur Psychiatry."},{"key":"184_CR23","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1089\/cap.2012.0029","volume":"23","author":"RL Findling","year":"2013","unstructured":"Findling RL, Cavu\u015f I, Pappadopulos E, Vanderburg DG, Schwartz JH, Gundapaneni BK, DelBello MP. Efficacy, long-term safety, and tolerability of ziprasidone in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol. 2013;23:545\u201357.","journal-title":"J Child Adolesc Psychopharmacol."},{"key":"184_CR24","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1089\/cap.2012.0068","volume":"23","author":"RL Findling","year":"2013","unstructured":"Findling RL, Cavu\u015f I, Pappadopulos E, Vanderburg DG, Schwartz JH, Gundapaneni BK, DelBello MP. Ziprasidone in adolescents with schizophrenia: results from a placebo-controlled efficacy and long-term open-extension study. J Child Adolesc Psychopharmacol. 2013;23:531\u201344.","journal-title":"J Child Adolesc Psychopharmacol."},{"key":"184_CR25","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/bdi.12042","volume":"15","author":"RL Findling","year":"2013","unstructured":"Findling RL, Correll CU, Nyilas M, Forbes RA, McQuade RD, Jin N, Ivanova S, Mankoski R, Carson WH, Carlson GA. Aripiprazole for the treatment of pediatric bipolar I disorder: a 30-week, randomized, placebo-controlled study. Bipolar Disord. 2013;15:138\u201349.","journal-title":"Bipolar Disord"},{"key":"184_CR26","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.4088\/JCP.09m05859yel","volume":"71","author":"RL Findling","year":"2010","unstructured":"Findling RL, Youngstrom EA, Fristad MA, Birmaher B, Kowatch RA, Arnold LE, et al. Characteristics of children with elevated symptoms of mania: the Longitudinal Assessment of Mania Symptoms (LAMS) study. J Clin Psychiatry. 2010;71:1664\u201372.","journal-title":"J Clin Psychiatry"},{"key":"184_CR27","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington: American Psychiatric Association; 2013.","edition":"5"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-016-0184-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40272-016-0184-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-016-0184-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T15:10:16Z","timestamp":1498317016000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40272-016-0184-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,26]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["184"],"URL":"https:\/\/doi.org\/10.1007\/s40272-016-0184-2","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,26]]}}}